Categories AlphaGraphs, Earnings, Technology

SNAP Earnings: Snap slips to loss in Q2 despite strong sales growth

Multimedia messaging platform Snap, Inc. (NYSE: SNAP) reported a net loss for the second quarter of 2022, compared to a profit last year, despite sales growing in double digits. The results missed the consensus estimates.

Second-quarter net loss, on an adjusted basis, was $0.02 per share, compared to earnings of $0.10 in the same period of 2021. Analysts had predicted a narrower loss for the most recent quarter.

On an unadjusted basis, the company reported a net loss of $422.07 million or $0.26 per share in the June quarter, compared to a loss of $151.66 million or $0.10 per share in the second quarter of last year. Meanwhile, revenues increased 13% annually to $1.11 billion, which missed analysts’ forecast.


Check this space to read management/analysts’ comments on Snap’s Q2 2022 earnings


“We are evolving our business and strategy to reaccelerate revenue growth, including innovating on our products, investing heavily in our direct response advertising business, and cultivating new sources of revenue to help diversify our topline growth,” said Evan Spiegel, CEO of Snap.

Prior Performance

  • Snap Q1 2022 earnings infographic

_________________________________________________________________________________________________________________

Stocks you may like:

Apple (AAPL) Stock

Microsoft (MSFT) Stock

Alphabet (GOOGL) Stock

International Business Machines Corp. (IBM) Stock

_________________________________________________________________________________________________________________

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top